This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1b07
From Proteopedia
| Line 1: | Line 1: | ||
| - | [[Image:1b07.png|left|200px]] | ||
| - | |||
{{STRUCTURE_1b07| PDB=1b07 | SCENE= }} | {{STRUCTURE_1b07| PDB=1b07 | SCENE= }} | ||
| - | |||
===CRK SH3 DOMAIN COMPLEXED WITH PEPTOID INHIBITOR=== | ===CRK SH3 DOMAIN COMPLEXED WITH PEPTOID INHIBITOR=== | ||
| + | {{ABSTRACT_PUBMED_9851931}} | ||
| - | + | ==Function== | |
| + | [[http://www.uniprot.org/uniprot/CRK_MOUSE CRK_MOUSE]] The Crk-I and Crk-II forms differ in their biological activities. Crk-II has less transforming activity than Crk-I. Crk-II mediates attachment-induced MAPK8 activation, membrane ruffling and cell motility in a Rac-dependent manner. Involved in phagocytosis of apoptotic cells and cell motility via its interaction with DOCK1 and DOCK4. May regulate the EFNA5-EPHA3 signaling. | ||
==About this Structure== | ==About this Structure== | ||
| - | [[1b07]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | [[1b07]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1B07 OCA]. |
==See Also== | ==See Also== | ||
| Line 14: | Line 13: | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:009851931</ref><references group="xtra"/> | + | <ref group="xtra">PMID:009851931</ref><references group="xtra"/><references/> |
| - | [[Category: | + | [[Category: Lk3 transgenic mice]] |
[[Category: Cohen, F E.]] | [[Category: Cohen, F E.]] | ||
[[Category: Lim, W A.]] | [[Category: Lim, W A.]] | ||
Revision as of 08:53, 25 December 2013
Contents |
CRK SH3 DOMAIN COMPLEXED WITH PEPTOID INHIBITOR
Template:ABSTRACT PUBMED 9851931
Function
[CRK_MOUSE] The Crk-I and Crk-II forms differ in their biological activities. Crk-II has less transforming activity than Crk-I. Crk-II mediates attachment-induced MAPK8 activation, membrane ruffling and cell motility in a Rac-dependent manner. Involved in phagocytosis of apoptotic cells and cell motility via its interaction with DOCK1 and DOCK4. May regulate the EFNA5-EPHA3 signaling.
About this Structure
1b07 is a 2 chain structure with sequence from Lk3 transgenic mice. Full crystallographic information is available from OCA.
See Also
Reference
- Nguyen JT, Turck CW, Cohen FE, Zuckermann RN, Lim WA. Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors. Science. 1998 Dec 11;282(5396):2088-92. PMID:9851931
